Results 271 to 280 of about 2,836,003 (403)

Purification and Characterization of Mouse Uterine Estrogen Receptor under Conditions of Varying Hormonal Status [PDF]

, 1987
TSUNEYOS HIHORIGOME, T S Golding, Valerie Quarmby, Dennis B. Lubahn, Kenneth S. McCarty, Kenneth S. Korach   +5 more
openalex   +1 more source

Real‐world treatment patterns among patients diagnosed with hormone receptor‐positive metastatic breast cancer in the USA

British Journal of Clinical Pharmacology, EarlyView.
Aims Clinical guidelines for breast cancer management have evolved in the past decade. However, limited evidence exists regarding uptake of novel drug classes in management of hormone receptor‐positive (HR+) metastatic breast cancer (MBC) in the USA and whether disparities exist by race and ethnicity.
Kexin Zhu, Coral O. Omene, Antoinette Stroup, Elisa V. Bandera, Farzin Khosrow‐Khavar   +4 more
wiley   +1 more source

Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma. [PDF]

Blood Adv
Özistanbullu D, Wilhelm R, Reichenbach G, Doll M, Bahrami K, Zöller N, Schnütgen F, König A, Scheller T, Winkler L, Spahn P, Jäger M, Nicolay JP, Pfeilschifter J, Schilling B, Kaufmann R, Koch A, Kippenberger S, Kleemann J, Meissner M.   +19 more
europepmc   +1 more source

Characterization of the estrogen-induced lipoprotein receptor of rat liver.

, 1986
A D Cooper, R Nutik, J Chen
openalex   +1 more source

Regulation of myocardial and vascular alpha-adrenergic receptor affinity. Effects of guanine nucleotides, cations, estrogen, and catecholamine depletion. [PDF]

, 1984
Wilson S. Colucci, Michael A. Gimbrone, R. Wayne Alexander   +2 more
openalex   +1 more source

Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities

BMEMat, EarlyView.
This review highlights the complex roles of cellular senescence in cancer progression and suppression, discusses the mechanisms and regulatory pathways involved, and evaluates the efficacy of the “One‐Two punch” sequential treatment approach while addressing emerging challenges in this novel therapeutic strategy.
Qiuming Pan, Ye Zhu, Zhi Ye, Huayang Zhang, Junxi Wang, Guozhong Yi, Zhiyong Li, Rongyang Xu, Luyao Wang, Zhenzhen Wu, Songtao Qi, Guanglong Huang, Shanqiang Qu   +12 more
wiley   +1 more source

Research progress on estrogen receptor-positive/progesterone receptor-negative breast cancer. [PDF]

Transl Oncol
Lu Z, Wang T, Wang L, Ming J.
europepmc   +1 more source

Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats. [PDF]

, 1982
Wilson S. Colucci, Michael A. Gimbrone, Margaret K. McLaughlin, W Halpern, R. Wayne Alexander   +4 more
openalex   +1 more source

Estrogen receptor beta in breast cancer

Molecular and Cellular Endocrinology, 2014
L. Haldosen, Chunyan Zhao, K. Dahlman-Wright   +2 more
semanticscholar   +1 more source

Deciphering the skeletal interoceptive circuitry to control bone homeostasis

BMEMat, EarlyView.
This review introduces the skeletal interoceptive circuitry, covering the ascending signals from bone tissues to the brain (sensors), the central neural circuits that integrate this information and dispatch commands (CPU), and the descending pathways that regulate bone homeostasis (effectors).
Yefeng Wu, Jiusi Guo, Zhen Chen, Fengwei Zhang, Billy Kwok Chong Chow, Zhuofan Chen, Kelvin Wai‐Kwok Yeung, Wei Qiao   +7 more
wiley   +1 more source